Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease

See also
Status	Clinical Trial	Phase
Terminated	`NCT04119115` - Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases
Active, not recruiting	`NCT04559581` - Post-marketing Surveillance of Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype in Japan
Recruiting	`NCT05151640` - INCHANGE - Nintedanib for Changes in Cough and Dyspnea in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation
Recruiting	`NCT02543073` - MSC for Treatment of Interstitial Lung Disease After Allo-HSCT	Phase 1/Phase 2
Completed	`NCT02251964` - Rituximab in Interstitial Pneumonitis	Phase 2/Phase 3
Terminated	`NCT01432080` - Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant	Phase 2
Completed	`NCT01442779` - Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis	Phase 2
Recruiting	`NCT05596760` - Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers	N/A
Recruiting	`NCT05866198` - Physical Activity and Quality of Life in Fibrotic Lung Diseases After Initiating Anti-fibrotic Therapy and Pulmonary Rehabilitation	N/A
Active, not recruiting	`NCT05321082` - A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)	Phase 3
Completed	`NCT04016168` - Idiopathic Pulmonary Fibrosis and Serum Bank
Recruiting	`NCT00258583` - Dorothy P. and Richard P. Simmons Center for ILD Research Registry
Recruiting	`NCT05855109` - Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors
Completed	`NCT05719233` - Assessment of Neuropsychiatric Function in Patients With Interstitial Lung Disease
Recruiting	`NCT04159129` - Effects of Pulmonary Rehabilitation on Walking Speed in Patients With COPD or ILD Patients
Completed	`NCT03313180` - A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis	Phase 3
Completed	`NCT05065190` - A Study to Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis	Phase 3
Completed	`NCT03136120` - Cryobiopsy Study to Assess Drug Distribution in Subjects With Suspected Interstitial Lung Disease
Recruiting	`NCT04930666` - BREATHE ALD: A Shared Decision-Making Intervention for Adults With Advanced Lung Disease
Recruiting	`NCT05503030` - Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) Patients

NCT number	NCT05957198
Study type	Observational
Source	Boehringer Ingelheim
Contact
Status	Completed
Phase
Start date	July 25, 2023
Completion date	September 26, 2023

Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms